Iridex (IRIX) Return on Capital Employed (2011 - 2026)
Iridex's (IRIX) quarterly Return on Capital Employed came in at 16.93% in Q2 2026, up 1422.0% year-on-year from 1.11% in Q2 2025, and down 2.39% quarter-over-quarter from 16.54% in Q1 2026.
Iridex (IRIX) Return on Capital Employed (2011 - 2026) Analysis & Trends
Iridex's Return on Capital Employed history runs 16 years deep, the most recent figure standing at 16.93% for Q2 2026.
- On a quarterly basis, Return on Capital Employed rose 1422.0% year-over-year to 16.93% in Q2 2026; TTM through Apr 2026 was 16.93%, a 1422.0% increase from a year earlier, with the FY2026 full-year figure at 16.13%, up 3839.0% from the prior year.
- Return on Capital Employed declined to 16.93% in Q2 2026 per IRIX's latest filing, from 16.54% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 16.54% in Q1 2026 and bottomed at 73.28% in Q3 2024.
- The 5-year median for Return on Capital Employed is 25.46% (2022), against an average of 33.62%.
- Across the five-year window, Return on Capital Employed sank 4071 bps in 2024 and soared 5588 bps in 2025, its largest moves.
- Year by year, Return on Capital Employed stood at 24.2% in 2022, then slumped by 90 bps to 46.08% in 2023, then tumbled by 38 bps to 63.45% in 2024, then jumped by 73 bps to 17.4% in 2025, then advanced by 3 bps to 16.93% in 2026.
- Per Business Quant, the three latest IRIX Return on Capital Employed figures stand at 16.93% (Q2 2026), 16.54% (Q1 2026), and 17.4% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 11.13% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 24.24% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.38% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 9.30% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Iridex | 15.93 Mn | 11.33 Mn | 4.74 Mn | -16.93% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | -16.93% |
| Jan 3, 2026 | -16.54% |
| Sep 27, 2025 | -17.40% |
| Jun 28, 2025 | -18.32% |
| Mar 29, 2025 | -31.16% |
| Dec 28, 2024 | -63.45% |
| Sep 28, 2024 | -73.28% |
| Jun 29, 2024 | -64.75% |
| Mar 30, 2024 | -60.20% |
| Dec 30, 2023 | -46.08% |
| Sep 30, 2023 | -32.57% |
| Jul 1, 2023 | -31.22% |
| Apr 1, 2023 | -26.72% |
| Dec 31, 2022 | -24.20% |
| Oct 1, 2022 | -23.31% |
| Jul 2, 2022 | -22.75% |
| Apr 2, 2022 | -19.07% |
| Jan 1, 2022 | -17.27% |
| Oct 2, 2021 | -18.59% |
| Jul 3, 2021 | -19.45% |